More on BRKR

- Summary
- Chart
- Profile
- Historical

Data

- Earnings (+53.1% Growth)
- Ratings (5.4 Score)
- Holders
- Dividends (0.3% Yield)

Financials

Income Statement
Balance Sheet
Cash Flow Statement

Upcoming Events

- Earnings (11/3/26 *Est.)

News

- Analyst Ratings
- Earnings Related
- Guidance
- Insider Trades
- Mgmt Changes
- M & A
- Retail Sales
- Rumors
- Stock Buybacks
More...

BRKR Balance Sheet

Click line-items for a historical chart and %
Cash and cash equivalents 278.7M
Restricted cash
Accounts receivable, net 223.6M
Inventory 483.1M
Other current assets 118.5M
Total current assets 1.27B
Property, plant and equipment, net 239.4M
Intangibles and other long-term assets 291.8M
Total assets 1.8B
Short-term borrowings
Current portion of long-term debt 20.2M
Accounts payable 93.3M
Customer advances 148.2M
Other current liabilities 290.9M
Total current liabilities 552.6M
Long-term debt 344.7M
Other long-term liabilities 199.7M
Commitments and contingencies (Note 12) 0
Preferred stock, $0.01 par value 5,000,000 shares authorized, none issued or outstanding 0
Common stock, $0.01 par value 260,000,000 shares authorized, 165,844,196 and 165,246,426 shares issued and 165,823,931 and 165,229,207 shares outstanding at June 30, 2011 and December 31, 2010, respectively
Treasury stock, at cost, 20,265 and 17,219 shares at June 30, 2011 and December 31,2010, respectively -234.9M
Other shareholders' equity 942.5M
Total shareholders' equity attributable to Bruker Corporation 693.9M
Noncontrolling interest in consolidated subsidiaries 7M
Total shareholders' equity 700.9M
Total liabilities and shareholders' equity 1.8B